ATG5 and metabolic syndrome: Expression levels of ATG5-ATG12 complex, mTOR, and p-AMPK were significantly downregulated in MetS vs. lean kidneys (Figure 1B, p = 0.006, p = 0.03, and p = 0.017, respectively).